Tecfidera
-
Glenmark Pharma gets nod to market relapsing multiple sclerosis drug
Glenmark Pharma has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for treatment of…
Read More »
Glenmark Pharma has received final approval from the US health regulator for Dimethyl Fumarate delayed-release capsules, used for treatment of…
Read More »